Prognostic models in myelodysplastic syndromes

被引：2
|
作者：
Della Porta, Matteo Giovanni [1 ,2 ]
机构：
[1] Fdn Ist Ricovero Cura & Carattere Sci IRCCS Polic, Dept Hematol Oncol, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 06期
关键词：
SCORING SYSTEM; MUTATIONS;
D O I：
10.1016/S2352-3026(15)00110-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E229 / E230
页数：2
相关论文
共 50 条
  • [31] Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes
    Komrokji, Rami S.
    Corrales-Yepez, Maria
    Kharfan-Dabaja, Mohamed A.
    Al Ali, Najla H.
    Padron, Eric
    Rollison, Dana E.
    Pinilla-Ibarz, Javier
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    Lancet, Jeffrey E.
    List, Alan F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (11) : 1006 - 1009
  • [32] Usefulness of Magnetic Resonance Imaging as a Prognostic Variable in Myelodysplastic Syndromes
    Ziolko, Ewa
    Kwiatkowska-Pamula, Anna
    Adamczyk, Tomasz
    Walecki, Jerzy
    Muc-Wierzgon, Malgorzata
    MEDICAL SCIENCE MONITOR, 2014, 20 : 1634 - 1640
  • [33] Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes
    Nomdedeu, Meritxell
    Calvo, Xavier
    Pereira, Arturo
    Carrio, Anna
    Sole, Francesc
    Luno, Elisa
    Cervera, Jose
    Vallespi, Teresa
    Munoz, Concha
    Gomez, Candida
    Arias, Amparo
    Such, Esperanza
    Sanz, Guillermo
    Grau, Javier
    Insunza, Andres
    Calasanz, Maria-Jose
    Ardanaz, Maria-Teresa
    Hernandez-Rivas, Jesus-Maria
    Azaceta, Gemma
    Alvarez, Sara
    Sanchez, Joaquin
    Martin, Maria-Luisa
    Bargay, Joan
    Gomez, Valle
    Cervero, Carlos-Javier
    Allegue, Maria-Jose
    Collado, Rosa
    Campo, Elias
    Esteve, Jordi
    Nomdedeu, Benet
    Costa, Dolors
    GENES CHROMOSOMES & CANCER, 2016, 55 (04) : 322 - 327
  • [34] Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Cazzola, Mario
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 349 - 352
  • [35] Jumping translocations in myelodysplastic syndromes
    Yeung, Cecilia C. S.
    Deeg, H. Joachim
    Pritchard, Colin
    Wu, David
    Fang, Min
    CANCER GENETICS, 2016, 209 (09) : 395 - 402
  • [36] Molecular genetics in myelodysplastic syndromes
    Haferlach, Torsten
    LEUKEMIA RESEARCH, 2012, 36 (12) : 1459 - 1462
  • [37] Diagnostics and Prognostication of Myelodysplastic Syndromes
    Zini, Gina
    ANNALS OF LABORATORY MEDICINE, 2017, 37 (06) : 465 - 474
  • [38] Myelodysplastic Syndromes: It Is All in the Genes
    Sekeres, Mikkael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 774 - 776
  • [39] Stem Cells in the Myelodysplastic Syndromes
    Zhan, Di
    Park, Christopher Y.
    FRONTIERS IN AGING, 2021, 2
  • [40] Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
    Yao, Chi-Yuan
    Hou, Hsin-An
    Lin, Tzung-Yi
    Lin, Chien-Chin
    Chou, Wen-Chien
    Tseng, Mei-Hsuan
    Chiang, Ying-Chieh
    Liu, Ming-Chih
    Liu, Chia-Wen
    Kuo, Yuan-Yeh
    Wu, Shang-Ju
    Liao, Xiu-Wen
    Lin, Chien-Ting
    Ko, Bor-Shen
    Chen, Chien-Yuan
    Hsu, Szu-Chun
    Li, Chi-Cheng
    Huang, Shang-Yi
    Yao, Ming
    Tang, Jih-Luh
    Tsay, Woei
    Liu, Chieh-Yu
    Tien, Hwei-Fang
    ONCOTARGET, 2016, 7 (39) : 63177 - 63188
12345